C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 39/395 (2006.01) C07K 16/24 (2006.01) C07K 16/46 (2006.01) C07K 17/02 (2006.01) C12N 5/10 (2006.01) C12N 5/18 (2006.01) G01N 33/564 (2006.01) G01N 33/577 (2006.01) G01N 33/68 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2171336
Chimeric and humanized IL4 MAbs derived from high affinity MAbs, pharmaceutical compositions containing same, and methods of treatment are provided.
L'invention concerne des anticorps monoclonaux ou "MAb" chimériques ou humanisés contre l'IL4 dérivés d'anticorps monoclonaux à haute affinité. L'invention concerne également des compositions pharmaceutiques contenant ces anticorps et les procédés de traitement correspondants.
Gross Mitchell Stuart
Holmes Stephen Dudley
Sylvester Daniel R.
Glaxosmithkline Llc
Gowling Lafleur Henderson Llp
Smithkline Beecham Corporation
Smithkline Beecham P.l.c.
LandOfFree
Recombinant il4 antibodies useful in treatment of il4... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant il4 antibodies useful in treatment of il4..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant il4 antibodies useful in treatment of il4... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2057559